Navigation Links
New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology
Date:10/21/2009

IRVINE, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that new clinical studies presented this week at the American Society of Anesthesiology (ASA) Annual Meeting in New Orleans, Louisiana, show Masimo noninvasive and continuous hemoglobin (SpHb(TM)) technology is reliable and accurate compared to invasive blood tests for both healthy subjects and hospitalized patients. Another study presented found Masimo PVI to be an accurate, reliable automatic noninvasive indicator of a patient's ability to respond to fluid.

Clinical Study Highlights

Accuracy of Noninvasive Hemoglobin Measurements by Pulse CO-Oximetry in Hemodilution Subjects (A184)(1), a clinical study led by Dr. Martin W. Allard at Loma Linda University in Loma Linda, California, compared SpHb measurements to 165 invasive laboratory measurements in 20 healthy adult patients undergoing hemodilution. All 20 patients had one unit of blood drawn through an arterial line while isolyte intravenous fluid was given (to compensate for the decrease in intravascular volume) until they reached a 30% reduction in hemoglobin or a maximum of 30 ml/kg of fluid. Blood samples were drawn after each 500 ml of fluid administered
'/>"/>

SOURCE Masimo Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Aribex, Inc., manufacturer of ... today introduced a new color option, black with gray ... dental and veterinary markets. The popular white with light ... will continue to be available and both models can ... (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental ...
(Date:5/22/2013)... 22, 2013 Attorney Advertising -- Bronstein, Gewirtz ... behalf of purchasers of the securities of AMAG ... -News).  The investigation focuses on whether the Company ... On May 22, 2013, Shares of AMAG ... the company announced in regulatory filing that it ...
(Date:5/22/2013)... and CAESAREA, Israel , May ... , New clinical data presented from the DEFLECT-I study ... Device reduces brain lesion volume during TAVR (Transcatheter Aortic ... Keystone Heart Scientific Advisory Board announces consensus on ... rising regarding the importance and need for cerebral protection ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4
... MELVILLE, N.Y., May 7, 2012 Henry Schein, Inc., (NASDAQ: ... products and services to office-based dental, medical and animal health ... Executive Vice President and Chief Financial Officer, will present at ... on May 9, 2012.  The conference is being held at ...
... MARLBOROUGH, Mass., May 7, 2012  CardioFocus, Inc., developer ... the treatment of atrial fibrillation (AF), announces that ... of the scientific sessions and during a private ... Rhythm Society,s 33rd Annual Scientific Sessions, May 9-12 ...
Cached Medicine Technology:Henry Schein To Present At The Deutsche Bank 37th Annual Health Care Conference 2Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012 2Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012 3
(Date:5/23/2013)... (PRWEB) May 23, 2013 According to ... [Converged Services; Policy Management; Subscriber Data Management (SDM); Telecom ... Forecasts and Analysis (2013 – 2018)", published by MarketsandMarkets, ... by 2018 at a CAGR of 9.15% from 2013 ... Market Data Tables , 84 Figures , ...
(Date:5/23/2013)... May 23, 2013 DRE, Inc. is ... as a solution to upgrade older model DRE ... the entire lighting system. , DRE and BFW ... DRE or BFW halogen headlights to LED with DRE’s ... C3 LED Conversion Kit provides a bright, clean and ...
(Date:5/23/2013)... Linda, CA (PRWEB) May 23, 2013 Located ... Fit Body Boot Camp Yorba Linda held its Grand Opening ... goal of spreading awareness about multiple sclerosis and physical fitness. ... premier health and wellness company, the fun filled Grand Opening ... camp prize to show the community what the Yorba ...
(Date:5/23/2013)... Los Angeles,Ca (PRWEB) May 23, 2013 ... with removing every sign associated with Rosacea. This condition ... skin and can affect a person’s self-image. Manufacturers have ... work to help constrict blood vessels near the surface ... and flushing. The new formula is available with special ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 In Florida, residents ... years. This doesn’t mean, however, that Florida’s good luck will ... Center . This year, he encourages residents, it is important ... season 2013, forecasters are predicting there to be a 50-percent ... WUFT . With hurricane season lasting from June 1 to ...
Breaking Medicine News(10 mins):Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 3Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 2Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 3Health News:Revitol Rosacea Now Comes with Anti-Inflammatory Ingredients to Remove Redness and Flushing 2Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2
... Common Shares Issued and Listed on OTCBB, ... (OTC Bullets and Board: CHHB) (,China,Bio-Immunity" or "the ... share exchange agreement with Lawford Asia Limited (,Lawford,).,According ... all of the issued and outstanding stock of ...
... Grant Stevens, MERRIMACK, N.H., Aug. 6 ... Medical Inc. announced today that Grant,Stevens, MD, will ... to offer,the SmoothShapes(R) system for longer lasting cellulite ... dynamic light therapy, in addition,to contoured rollers and ...
... eDiets.com,Inc. (Nasdaq: DIET ), leveraging the power of ... to everyone, today announced,results for the second quarter and ... the second quarter of 2008 were $6.5 million, compared ... for the quarter was $(3.1),million, or $(0.12) per diluted ...
... Raritan, NJ, August 6, 2008 The nation,s first, ... (cSSTIs), known as SSTIR (the Skin and Soft Tissue ... plans to enroll more than 1,200 hospitalized patients by ... better understand treatment patterns and provide data to help ...
... study finds , , WEDNESDAY, Aug. 6 (HealthDay News) -- Stroke ... times as likely to die in the hospital or be ... new Canadian study suggests. , The finding is based ... recovery from an ischemic stroke. Ischemic strokes are the most ...
... than to adults. That,s one reason why abstinence-only ... sexual activity, according to new University of Washington research., , ... treated abstinence and sexual activity as opposites. However, teenagers ... Tatiana Masters, lead author of a new study and ...
Cached Medicine News:Health News:China Bio-Immunity Corporation Completes Share Exchange and Reverse Merger 2Health News:China Bio-Immunity Corporation Completes Share Exchange and Reverse Merger 3Health News:China Bio-Immunity Corporation Completes Share Exchange and Reverse Merger 4Health News:New Anti-Cellulite Treatment Prepares Women for Fall's Short Skirts 2Health News:New Anti-Cellulite Treatment Prepares Women for Fall's Short Skirts 3Health News:eDiets.com(R) Announces Q2 2008 Results 2Health News:eDiets.com(R) Announces Q2 2008 Results 3Health News:eDiets.com(R) Announces Q2 2008 Results 4Health News:eDiets.com(R) Announces Q2 2008 Results 5Health News:eDiets.com(R) Announces Q2 2008 Results 6Health News:eDiets.com(R) Announces Q2 2008 Results 7Health News:Ortho-McNeil initiates first-of-its-kind skin infection registry 2Health News:GI Bleeding After Stroke Raises Death Risk 2Health News:GI Bleeding After Stroke Raises Death Risk 3Health News:When it comes to abstinence teens, adults aren't speaking the same language 2Health News:When it comes to abstinence teens, adults aren't speaking the same language 3
Bartels Clostridium difficile Toxin A Enzyme Immunoassay (EIA) is intended for the qualitative detection of Clostridium difficile Toxin A in human faecal specimens as an aid in the diagnosis of Clost...
One step Immuno-Chromatographic Assay for the detection of C. difficile toxin A....
... CCD cameras provide fast, accurate, reliable and ... quality at an excellent price. , , ... TOMEY TR-4000 Auto Refractor provides highly accurate ... is obtained simply by pushing a button. ...
... Rechargeable, cordless slit-lamp microscope Portable, for ... Easy selection of slit width , ... halogen lamp light source , Simultaneous ... pack , Supports digital / video ...
Medicine Products: